Disease treatment in horses encompasses a range of medical interventions and management strategies aimed at addressing various health conditions affecting equine species. These treatments can include pharmacological approaches, such as the administration of antibiotics, anti-inflammatory drugs, and antiparasitic medications, as well as non-pharmacological methods like physical therapy, dietary adjustments, and surgical procedures. The selection of appropriate treatments depends on the specific disease, its severity, and the individual needs of the horse. This topic brings together peer-reviewed research studies and scholarly articles that explore the efficacy, safety, and advancements in therapeutic options for equine diseases, providing insights into best practices and emerging trends in equine veterinary medicine.
A clinical evaluation of a new, purified, heat-treated equine rabies immunoglobulin (PHT-Erig), F(ab')2 preparation, was carried out in Thailand and in the Philippines-two countries where rabies is endemic. An initial prospective, randomised, controlled trial (Study 1), compared the safety and pharmacokinetics (serum concentrations of rabies antibodies) after administration either of PHT-Erig or of a commercially-available, equine rabies immune globulin (Erig PMC). A second trial (Study 2) simulated post-exposure rabies prophylaxis by using a reference cell culture vaccine, the purified Vero-c...
A review of the literature is given concerning the anatomy and pathophysiology of the equine penis with regard to priapism: a prolonged erection of the penis not associated with sexual arousal. Several treatment options, such as flushing of the corpus cavernosum penis with heparinized saline and the creation of shunt between the corpus cavernosum penis and the corpus spongiosum penis are discussed. Subsequently, a case of priapism in a stallion following the injection of acepromazine, is discussed. The priapism resolved after the corpus cavernosum penis was flushed with the stallion under gene...
The research article describes the treatment, recovery process, and prognosis of a 2-month old Quarter Horse, who suffered from severe lameness in the left forelimb due to an avulsion-type fracture […]
Stahl LT, Wehrend A.This article provides an overview of the clinically relevant functions and metabolic processes of selenium. Especially equine and bovine neonates are affected by selenium deficiency leading to serious consequences. Severe selenium deficiency may especially result in skeletal and/or heart muscles damage, which can result in serious illness and death of the animal. The typical clinical picture is known under various names and is often referred to as rhabdomyolysis, or more precisely as nutritional muscular dystrophy (NMD) and in the past usually as white muscle disease. Early recognition of nutr...
Songsungthong W, Pornthanakasem W, Leartsakulpanich U, Srijuntongsiri G.The ability to accurately and rapidly identify causative agents of infectious diseases facilitates precise treatment, improves clinical outcomes, and augments epidemiology studies. For many veterinary and zoonotic pathogens, however, simple molecular tests for species identification are not available. causes severe diseases, such as sleepy foal disease, septicemia, and meningitis in horses and pigs. can also cause severe diseases in humans bitten by infected animals. Existing identification methods are biochemical tests, 16S rRNA gene amplification followed by DNA sequencing, and MALDI-TOF ...
Ilbeigi K, Mabille D, Roy R, Bundschuh M, Van de Velde E, Hulpia F, Van Calenbergh S, Caljon G.Surra and Dourine are widespread diseases caused by two protozoan parasites Trypanosoma brucei evansi and Trypanosoma brucei equiperdum, respectively. A wide range of animals including camels, horses, cattle and buffaloes are susceptible to infection. These diseases pose a significant socio-economic burden, primarily due to the limited therapeutic options and the complications associated with toxicity and drug resistance, making disease management particularly challenging. This study evaluated the potential of 3'-deoxytubercidin, a previously identified antitrypanosomal nucleoside, as a therap...